Jacobs Levy Equity Management’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
Other funds holding XRAY
AI
SCA
CB
Jacobs Levy Equity Management's XRAY Position: Q2 2026 in Review
Jacobs Levy Equity Management reduced its Dentsply Sirona (XRAY) stake by 97% in Q2 2026, selling an estimated $7.61M and leaving 24,936 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #889.
Jacobs Levy Equity Management first reported a position in XRAY in Q2 2019 and has held it in 15 quarters since. The position peaked at $58.5M in Q3 2025. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.
- Jacobs Levy Equity Management held 24,936 shares of Dentsply Sirona worth $265K as of Q2 2026.
- Jacobs Levy Equity Management sold 697,332 Dentsply Sirona shares in Q2 2026, an estimated $7.61M.
- Dentsply Sirona made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #889 holding.
- Jacobs Levy Equity Management first reported a position in Dentsply Sirona in Q2 2019 and has held it in 15 quarters since.
- Jacobs Levy Equity Management's Dentsply Sirona position peaked at $58.5M in Q3 2025.
- 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.